Unlocking the health benefits of cannabinoids

Our believe

Everybody deserves to live a healthy, balanced life.

The Cannabis’ Potential

After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives.

Our purpose

Unlock the benefits of cannabis for health and wellbeing and make them widely accessible to people in Europe.

Why cannabinoids are not at full potential yet

Research backlog

We explore cannabis’ potential with research and development

Missing access

We make cannabis accessible through our brands.

Distorted perception

We address cannabis’ image with our medical and political advisory board of experts.

Looking for evidence-based expert insights?

Find out more about the Basel-Landschaft cannabis

Status quo of our industry

Against the backdrop of the ongoing legalisation and acceptance of cannabis in North America and worldwide, both for medical and recreational purposes, Europe is going its own way. With over 700 million inhabitants in continental Europe and 500 million within the EU, the European cannabis market is estimated to be worth more than €100 billion by 2028.
Originating in Europe's largest cannabis market – Germany – the Sanity Group has specialised in the complex regulations and requirements surrounding cannabis since its inception in order to further explore the plant's potential and make it accessible in a controlled manner.

Latest posts

March 9, 2026
Sanity Group
Das neue Cannabisgesetz (CanG): Was bedeutet es für Patient:innen? 
February 17, 2026
Sanity Group
Hola
February 17, 2026
Sanity Group
Hello world!
February 12, 2026
Sanity Group
Hello world!
Get in touch

For general enquiries, please email info@sanitygroup.com. For specific topics you can reach the right team in the sidebar. You’ll also find links for cultivation collaborations and pilot studies in our footer.

Interested in a career at Sanity Group?

Visit careers page